Pancreas-Adipose-Liver Axis: Role of Ghrelin and Insulin in Alcoholic Fatty Liver
胰腺-脂肪-肝轴:生长素释放肽和胰岛素在酒精性脂肪肝中的作用
基本信息
- 批准号:9268735
- 负责人:
- 金额:$ 12.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-05-05 至 2021-04-30
- 项目状态:已结题
- 来源:
- 关键词:AdipocytesAdipose tissueAlcohol consumptionAlcoholic Fatty LiverAlcoholic Liver DiseasesAlcoholsAnimalsAttenuatedBeta CellBiologicalCell LineCellsChronicCirrhosisDataData ReportingDepositionDevelopmentDietEthanolExocytosisFatty AcidsFatty LiverFatty acid glycerol estersGoalsHealthHepaticHepatocyteHormonesImpairmentIn VitroInjuryInsulinInsulin ResistanceIslets of LangerhansKnockout MiceLaboratoriesLipolysisLipoproteinsLiverLiver FibrosisLiver diseasesMetabolicModelingMusOrganPancreasPathway interactionsPlasmaPlasmidsPlayPredispositionPrimary carcinoma of the liver cellsProteinsRattusReportingResistanceRoleSerumSignal TransductionSmall Interfering RNASteatohepatitisStomachStructure of beta Cell of isletTechnologyTestingTransgenesTriglyceridesWorkalcohol effectalcohol exposurefeedingghrelinghrelin receptorimprovedin vivoinjuredinsightinsulin secretionlipid metabolismmRNA Expressionnoveloverexpressionproblem drinkerprotein transportpublic health relevancerab GTP-Binding Proteinsresponseuptake
项目摘要
DESCRIPTION (provided by applicant): Alcohol-induced liver disease (ALD) is a major health problem both in the US and worldwide. Fatty liver (steatosis) is the earliest and most common response of the liver to excessive ethanol consumption that predisposes the fatty liver to develop alcoholic steatohepatitis (ASH), hepatic fibrosis, cirrhosis and even hepatocellular carcinoma. Central among the many mechanisms proposed to play a role in the development of alcoholic hepatic steatosis is increased circulating fatty acids. Recent evidence suggests that alcohol-induced mobilization from adipose tissue is responsible for the increased circulating fatty acids and their enhanced hepatic uptake for subsequent fat accumulation. Insulin influences lipid metabolism throughout the body. Two of the important metabolic actions of insulin are to 1) promote the export of lipoproteins from the liver for storage in adipose tissue and 2) inhibit lipolysis in adipocytes. It is known that chronic ethanol exposure in rats disrupts insulin-dependent signal transduction thereby promoting lipolysis in adipocytes. In recent studies from our laboratory we found that chronic alcohol feeding, as expected, decreased plasma insulin levels. In addition, surprisingly, we also found increased plasma ghrelin levels in chronic alcohol-fed rats. Ghrelin, a hormone mainly secreted from stomach, inhibits insulin secretion from pancreatic β-cells. Another protein known to be involved in insulin secretion is Rab3D, a small Ca2+-dependent Rab GTPase. Involvement of Rab3D is especially intriguing since we have recently reported that this protein is dramatically reduced in livers of ethanol-fed rats, and likely plays a role in altered protein trafficking in the alcohol-injured liver. Our preliminary data reported here shows that Rab3D is also decreased in pancreatic islets of ethanol-fed rats. On the basis of our preliminary data, and since insulin secretion has been shown to be significantly decreased in pancreatic islets of ethanol treated animals, we put forth the following hypothesis: Alcohol-induced increase in serum ghrelin levels and decrease in pancreatic Rab3D content both contribute to impaired insulin secretion from pancreatic β-cells. Consequently, the reduced circulating insulin levels resulting from these alterations contribute to
increased fatty acid mobilization from adipose tissue to liver, thereby exacerbating hepatic steatosis. We will utilize a variety of state-of-the art technologies to pursue novel and innovativ biological concepts that we have put forth in this application that include: one, alcohol administration elevates circulating ghrelin levels, resulting in impaired insulin secretion by pancreatic β-cells; two, ethanol-associated lowering of Rab3D impairs insulin exocytosis in β-cells; three, increased ghrelin and reduced insulin work together to modulate fat metabolism in liver and adipose tissue favoring hepatic steatosis, and four, antagonists of ghrelin could help attenuate alcohol-induced organ injury. Successful completion of these studies will provide new insights on the roles of the important players, ghrelin and Rab3D, in modulating the pancreas-adipose-liver axis after alcohol exposure.
描述(由申请人提供):酒精性肝病 (ALD) 是美国乃至全世界的一个主要健康问题。脂肪肝(脂肪变性)是肝脏对过量乙醇摄入的最早且最常见的反应,容易诱发脂肪肝。肝脏发展为酒精性脂肪性肝炎(ASH)、肝纤维化、肝硬化甚至肝细胞癌是在酒精性肝的发展中发挥作用的许多机制中的核心。脂肪变性是指循环脂肪酸增加。最近的证据表明,酒精引起的脂肪组织动员是导致循环脂肪酸增加的原因,并且肝脏对随后的脂肪积累的吸收增强,胰岛素影响了全身的脂质代谢。胰岛素的作用是 1) 促进脂蛋白从肝脏输出并储存在脂肪组织中,以及 2) 抑制脂肪细胞中的脂肪分解 已知大鼠长期暴露于乙醇会破坏胰岛素依赖性信号转导。在我们实验室最近的研究中,我们发现,正如预期的那样,长期饮酒会降低血浆胰岛素水平。此外,令人惊讶的是,我们还发现长期饮酒的大鼠血浆生长素释放肽水平升高。由胃分泌,抑制胰腺 β 细胞的胰岛素分泌 另一种已知参与胰岛素分泌的蛋白质是 Rab3D,一种小型 Ca2+ 依赖性 Rab GTP 酶。特别有趣的是,我们最近报道称,这种蛋白质在喂食乙醇的大鼠的肝脏中显着减少,并且可能在酒精损伤的肝脏中蛋白质运输的改变中发挥作用。我们在此报告的初步数据表明,Rab3D 在胰腺中也减少了。根据我们的初步数据,由于乙醇治疗动物的胰岛胰岛素分泌显着减少,我们提出以下假设:酒精诱导的血清增加。 ghrelin 水平和胰腺 Rab3D 含量的减少都会导致胰腺 β 细胞的胰岛素分泌受损,这些改变导致循环胰岛素水平降低。
增加脂肪酸从脂肪组织到肝脏的动员,从而加剧肝脏脂肪变性。我们将利用各种最先进的技术来追求我们在本申请中提出的新颖和创新的生物学概念,其中包括:一、饮酒。提高循环胃饥饿素水平,导致胰腺 β 细胞胰岛素分泌受损;二,与乙醇相关的 Rab3D 降低损害 β 细胞中的胰岛素胞吐作用;生长素释放肽和减少的胰岛素共同调节肝脏和脂肪组织中的脂肪代谢,有利于肝脂肪变性,第四,生长素释放肽拮抗剂可以帮助减轻酒精引起的器官损伤,这些研究的成功完成将为了解重要参与者的作用提供新的见解。 、ghrelin 和 Rab3D,在酒精暴露后调节胰腺-脂肪-肝脏轴。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Karuna Rasineni其他文献
Karuna Rasineni的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Karuna Rasineni', 18)}}的其他基金
Role of alcohol-induced ghrelin in modulating organ crosstalk to promote the development of fatty liver disease
酒精诱导的胃饥饿素在调节器官串扰促进脂肪肝发展中的作用
- 批准号:
10428677 - 财政年份:2021
- 资助金额:
$ 12.06万 - 项目类别:
Role of alcohol-induced ghrelin in modulating organ crosstalk to promote the development of fatty liver disease
酒精诱导的胃饥饿素在调节器官串扰促进脂肪肝发展中的作用
- 批准号:
10211947 - 财政年份:2021
- 资助金额:
$ 12.06万 - 项目类别:
Role of alcohol-induced ghrelin in modulating organ crosstalk to promote the development of fatty liver disease
酒精诱导的胃饥饿素在调节器官串扰促进脂肪肝发展中的作用
- 批准号:
10211947 - 财政年份:2021
- 资助金额:
$ 12.06万 - 项目类别:
Role of alcohol-induced ghrelin in modulating organ crosstalk to promote the development of fatty liver disease
酒精诱导的胃饥饿素在调节器官串扰促进脂肪肝发展中的作用
- 批准号:
10625844 - 财政年份:2021
- 资助金额:
$ 12.06万 - 项目类别:
Pancreas-Adipose-Liver Axis: Role of Ghrelin and Insulin in Alcoholic Fatty Liver
胰腺-脂肪-肝轴:生长素释放肽和胰岛素在酒精性脂肪肝中的作用
- 批准号:
9912676 - 财政年份:2016
- 资助金额:
$ 12.06万 - 项目类别:
Pancreas-Adipose-Liver Axis: Role of Ghrelin and Insulin in Alcoholic Fatty Liver
胰腺-脂肪-肝轴:生长素释放肽和胰岛素在酒精性脂肪肝中的作用
- 批准号:
9109961 - 财政年份:2016
- 资助金额:
$ 12.06万 - 项目类别:
相似国自然基金
基于“脂肪-肝脏对话”探讨脂肪组织代谢重编程相关活性代谢因子AMRM2调控RNF8/RXRα/PPARα轴在肝脏脂质代谢稳态维持中的作用与机制
- 批准号:82300971
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
巨噬细胞GP73-CXCL5调节脂肪组织适应性产热的机制研究
- 批准号:32300573
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
不同脂肪组织及其驻留巨噬细胞调控小鼠禁食稳态的系统研究
- 批准号:32301235
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
脂肪干细胞外泌体miRNA-299a-3p调控巨噬细胞Thbs1缓解脂肪组织衰老的机制研究
- 批准号:82301753
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
棕色脂肪组织源外泌体circ-JARID2调控线粒体功能在延缓卵巢衰老中的作用及机制研究
- 批准号:82301848
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Aberrant BCAA utilization in alcohol-induced metabolic dysregulation
酒精引起的代谢失调中支链氨基酸的异常利用
- 批准号:
10730925 - 财政年份:2023
- 资助金额:
$ 12.06万 - 项目类别:
Synergy of lipolysis and lipophagy in alcoholic liver disease
脂肪分解和脂肪吞噬在酒精性肝病中的协同作用
- 批准号:
10489818 - 财政年份:2021
- 资助金额:
$ 12.06万 - 项目类别:
Synergy of lipolysis and lipophagy in alcoholic liver disease
脂肪分解和脂肪吞噬在酒精性肝病中的协同作用
- 批准号:
10455130 - 财政年份:2021
- 资助金额:
$ 12.06万 - 项目类别:
FABP4 Released from Steatotic Hepatocytes in Alcoholic Liver Disease Enhances Hepatic Tumor Progression
酒精性肝病中脂肪肝细胞释放的 FABP4 促进肝肿瘤进展
- 批准号:
10380190 - 财政年份:2021
- 资助金额:
$ 12.06万 - 项目类别:
FABP4 Released from Steatotic Hepatocytes in Alcoholic Liver Disease Enhances Hepatic Tumor Progression
酒精性肝病中脂肪肝细胞释放的 FABP4 促进肝肿瘤进展
- 批准号:
10491369 - 财政年份:2021
- 资助金额:
$ 12.06万 - 项目类别: